IP Library › Assignment 052923/0300
Patent Assignment
Reel/Frame 052923/0300

Assignment of Assignor's Interest

Recorded: 2020-06-12 Pages: 13
Assignors
MEKONNEN, BELEW
Executed: 2017-12-14
BUTERA, JOHN A.
Executed: 2017-12-14
HUANG, JIANXING
Executed: 2017-12-14
PATEL, HEMANTBHAI
Executed: 2020-02-19
Assignee
HAGER BIOSCIENCES
116 RESEARCH DR., SUITE 265, BETHLEHEM, PENNSYLVANIA, 18015
Covered Properties (2)
Benzodiazepine Derivatives, Compositions, and Methods for Treating Cognitive Impairment
Application: 16/471,237 →
Publication: US 2021/0253588
Benzodiazepine Derivatives, Compositions, and Methods for Treating Cognitive Impairment
Application: 62/436,272 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 24, 2018
From: HAGER BIOSCIENCES
To: AGENEBIO, INC.
Reel/Frame 044716/0206 →
Assignment of Assignor's Interest Jan 24, 2018
From: MEKONNEN, BELEW; BUTERA, JOHN A.; HUANG, JIANXING
To: HAGER BIOSCIENCES
Reel/Frame 044716/0197 →
Confirmatory License Aug 7, 2018
From: AGENEBIO INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046730/0692 →
Assignment of Assignor's Interest Jun 17, 2019
From: MEKONNEN, BELEW; BUTERA, JOHN A.; HUANG, JIANXING
To: HAGER BIOSCIENCES
Reel/Frame 049493/0375 →
Assignment of Assignor's Interest Jun 17, 2019
From: HAGER BIOSCIENCES
To: AGENEBIO, INC.
Reel/Frame 049493/0399 →
Assignment of Assignor's Interest Oct 31, 2019
From: HAGER BIOSCIENCES
To: AGENEBIO, INC.
Reel/Frame 050870/0692 →
Assignment of Assignor's Interest Oct 31, 2019
From: MEKONNEN, BELEW; BUTERA, JOHN A.; HUANG, JIANXING
To: HAGER BIOSCIENCES
Reel/Frame 050870/0661 →
Assignment of Assignor's Interest Jun 12, 2020
From: HAGER BIOSCIENCES
To: AGENEBIO, INC.
Reel/Frame 052923/0313 →
Corrective Assignment to Correct the Execution Dation Date for the Assignor Is 12/04/2017 Previously Recorded at Reel: 052923 Frame: 0313. Assignor(S) Hereby Confirms the Assignment. Nov 18, 2022
From: HAGER BIOSCIENCES
To: AGENEBIO, INC.
Reel/Frame 061966/0601 →